Clinical Trial

TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors

Name: TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors — clinical trial record (NCT07342738)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-arm, Multicenter, open-label clinical study aimed at evaluating the safety and efficacy of TCR-T injection in patients with advanced solid tumors induced by KRAS mutations.

Trial Details

NCT Number	NCT07342738
Lead Sponsor	Sun Yat-sen University Collaborators: Shanghai Bintie Biotechnology Co., Ltd
Conditions	KRAS G12V, KRAS G12D, Solid Tumor
Enrollment	25 participants
Start Date	2026-02-01
Primary Completion	2028-02-01 (estimated)
Study Completion	2029-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-15